StockData
YDESNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as YDESW

YD Bio Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026
$6.12+0.20 (+3.38%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

SEC filings

15 of YD Bio's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report6-KJun 30, 2026Sep 1, 2026SEC EDGAR
Current report6-KAug 11, 2026Aug 11, 2026SEC EDGAR
Current report6-KApr 30, 2026May 1, 2026SEC EDGAR
Annual report20-FDec 31, 2025Apr 30, 2026SEC EDGAR
Current report6-KFeb 26, 2026Feb 26, 2026SEC EDGAR
Current report6-KJan 30, 2026Jan 30, 2026SEC EDGAR
Current report6-KJan 21, 2026Jan 21, 2026SEC EDGAR
Current report6-KJan 16, 2026Jan 16, 2026SEC EDGAR
Current report6-KJan 15, 2026Jan 15, 2026SEC EDGAR
Current report6-KJan 6, 2026Jan 6, 2026SEC EDGAR
Current report6-KNov 17, 2025Nov 17, 2025SEC EDGAR
Current report6-KJun 30, 2025Sep 30, 2025SEC EDGAR
Current report6-KSep 26, 2025Sep 26, 2025SEC EDGAR
Current report6-KSep 19, 2025Sep 19, 2025SEC EDGAR
Current report6-KAug 15, 2025Aug 15, 2025SEC EDGAR